These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 19421928)
21. [Changes in glucose tolerance in elderly]. Lerman-Garber I; Rosales-Calderón M Rev Invest Clin; 2010; 62(4):312-7. PubMed ID: 21222309 [TBL] [Abstract][Full Text] [Related]
22. Making sense of it: roles of the sensory circumventricular organs in feeding and regulation of energy homeostasis. Fry M; Hoyda TD; Ferguson AV Exp Biol Med (Maywood); 2007 Jan; 232(1):14-26. PubMed ID: 17202582 [TBL] [Abstract][Full Text] [Related]
23. [Pathogenic mechanism of type 2 diabetes mellitus from impaired glucose tolerance/borderline type and its reversibility]. Yoshimoto K; Ozawa S; Ishida H Nihon Rinsho; 2005 Feb; 63 Suppl 2():95-9. PubMed ID: 15779352 [No Abstract] [Full Text] [Related]
24. The role of CNS fuel sensing in energy and glucose regulation. Cota D; Proulx K; Seeley RJ Gastroenterology; 2007 May; 132(6):2158-68. PubMed ID: 17498509 [TBL] [Abstract][Full Text] [Related]
25. Novel factors as therapeutic targets to treat diabetes. Focus on leptin and ghrelin. Gómez R; Lago F; Gómez-Reino JJ; Gualillo O Expert Opin Ther Targets; 2009 May; 13(5):583-91. PubMed ID: 19397477 [TBL] [Abstract][Full Text] [Related]
26. Glucocorticoids and melanocortins in the regulation of body weight in humans. Fehm HL; Born J; Peters A Horm Metab Res; 2004 Jun; 36(6):360-4. PubMed ID: 15241724 [TBL] [Abstract][Full Text] [Related]
27. The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity. Masaki T; Yoshimatsu H Trends Pharmacol Sci; 2006 May; 27(5):279-84. PubMed ID: 16584790 [TBL] [Abstract][Full Text] [Related]
28. [Leptin and its association with obesity and type 2 diabetes]. Almanza-Pérez JC; Blancas-Flores G; García-Macedo R; Alarcón-Aguilar FJ; Cruz M Gac Med Mex; 2008; 144(6):535-42. PubMed ID: 19112726 [TBL] [Abstract][Full Text] [Related]
31. Hepatic glucose metabolism and insulin resistance in NIDDM and obesity. Barrett EJ; Liu Z Baillieres Clin Endocrinol Metab; 1993 Oct; 7(4):875-901. PubMed ID: 8304916 [No Abstract] [Full Text] [Related]
32. A teleological view of obesity, diabetes and hypertension. Landsberg L Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):863-7. PubMed ID: 16922822 [TBL] [Abstract][Full Text] [Related]
33. Hypothalamic control of hepatic glucose production and its potential role in insulin resistance. Buettner C; Camacho RC Endocrinol Metab Clin North Am; 2008 Dec; 37(4):825-40. PubMed ID: 19026934 [TBL] [Abstract][Full Text] [Related]
34. Failures of feedback: rush hour along the highway to obesity. Gade W; Gade J; Collins M; Schmit J; Schupp N Clin Lab Sci; 2010; 23(1):39-50. PubMed ID: 20218094 [TBL] [Abstract][Full Text] [Related]
35. [Pathophysiology and management of impaired glucose tolerance and diabetes with metabolic syndrome]. Ohara T Nihon Rinsho; 2006 Dec; 64 Suppl 9():428-32. PubMed ID: 17458257 [No Abstract] [Full Text] [Related]
36. Insulin resistance in the defense against obesity. Saltiel AR Cell Metab; 2012 Jun; 15(6):798-804. PubMed ID: 22682220 [TBL] [Abstract][Full Text] [Related]
37. Composed by leptin. Early in life, appetite hormone sets up circuitry that controls food intake during adulthood. Beckman M Sci Aging Knowledge Environ; 2004 Apr; 2004(14):nf37. PubMed ID: 15071175 [No Abstract] [Full Text] [Related]